This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Ajet Saxena: Innovator in Pharmaceutical Composition for Diabetes Treatment
Introduction
Ajet Saxena is a notable inventor based in Lucknow, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and dyslipidemia. His innovative work has led to the development of a unique bioactive fraction that holds promise for effective treatment options.
Latest Patents
Ajet Saxena holds 1 patent for his invention titled "Pharmaceutical composition for treatment of diabetes and dyslipidemia." This patent describes a bioactive fraction that is beneficial for treating diabetes and dyslipidemia. The composition can be utilized as an antidiabetic and antidyslipidemic agent. Additionally, it outlines a process for preparing this bioactive fraction from isomeric xyloccensins. The patent also includes pharmaceutical compositions that comprise a therapeutically effective amount of these compounds, along with acceptable carriers and additives.
Career Highlights
Ajet Saxena is associated with the Council of Scientific and Industrial Research, where he has been involved in groundbreaking research. His work focuses on developing pharmaceutical solutions that address critical health issues, particularly those related to metabolic disorders.
Collaborations
Ajet has collaborated with esteemed colleagues such as Deepak Raina and Mahendra Nath Srivastava. Their combined expertise has contributed to advancing research in the pharmaceutical field.
Conclusion
Ajet Saxena's innovative contributions to pharmaceutical compositions for diabetes treatment highlight his role as a significant inventor in the industry. His work not only showcases his expertise but also offers hope for improved treatment options for patients suffering from these conditions.